Aller au contenu principal
Profil bibliographique

Akwasi Agyeman

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

43Publications signalées
952Citations signalées
0Affiliations récentes

Les domaines associés

Hedgehog Signaling Pathway StudiesCancer-related Molecular PathwaysEpigenetics and DNA MethylationGenetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalities

Les publications récentes

Accès ouvert 2023 other OpenAlex

Data from Blocking Hedgehog Survival Signaling at the Level of the GLI Genes Induces DNA Damage and Extensive Cell Death in Human Colon Carcinoma Cells

Tapati Mazumdar, Jennifer DeVecchio, Akwasi Agyeman, Ting Shi et autres

Abstract Canonical Hedgehog (HH) signaling is characterized by Smoothened (Smo)-dependent activation of the transcription factors Gli1 and Gli2, which regulate HH target genes. In human colon carcinoma cells, treatment with the Gli small-molecule inhibitor GANT61 induces extensive cell death in contrast to …

0 citations
Accès ouvert 2023 other OpenAlex

Data from Blocking Hedgehog Survival Signaling at the Level of the GLI Genes Induces DNA Damage and Extensive Cell Death in Human Colon Carcinoma Cells

Tapati Mazumdar, Jennifer DeVecchio, Akwasi Agyeman, Ting Shi et autres

Abstract Canonical Hedgehog (HH) signaling is characterized by Smoothened (Smo)-dependent activation of the transcription factors Gli1 and Gli2, which regulate HH target genes. In human colon carcinoma cells, treatment with the Gli small-molecule inhibitor GANT61 induces extensive cell death in contrast to …

0 citations
Accès ouvert 2020 article OpenAlex

Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look

Joseph Maakaron, Christina Liscynesky, Zeinab El Boghdadly, Ying Huang et autres

Prophylaxis with fluoroquinolone (FQ) for patients undergoing autologous stem cell transplantation (ASCT) remains controversial. We performed a retrospective review of patients undergoing ASCT with and without bacterial prophylaxis to compare endpoints of interest. In accordance with institutional policy, patients undergoing ASCT for …

us (code pays fourni par la source)

17 citations Transplantation and Cellular Therapy
Accès ouvert 2020 article OpenAlex

CAR T-Cell Therapy: Clinical Outcomes, Patient Selection and Financial Metrics with Tisagenlecleucel and Axicabtagene Ciloleucel, a Single Center Experience

Nathan Denlinger, Zachary Braunstein, Akwasi Agyeman, Zebulun Purdin et autres

Background Axicabtagene ciloleucel (A) and Tisagenlecleucel (T) are FDA approved CAR T cell products that have changed treatment (tx) for patients (pts) w/ relapsed/refractory lymphoma. The high tx cost has implications in selection of pts for CAR T and data comparing these …

us (code pays fourni par la source)

4 citations Transplantation and Cellular Therapy

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.